R
Roberta Kahn
Researcher at National Institute on Drug Abuse
Publications - 23
Citations - 1306
Roberta Kahn is an academic researcher from National Institute on Drug Abuse. The author has contributed to research in topics: Placebo & Cocaine dependence. The author has an hindex of 15, co-authored 22 publications receiving 1212 citations. Previous affiliations of Roberta Kahn include National Institutes of Health.
Papers
More filters
Journal ArticleDOI
Bupropion for the Treatment of Methamphetamine Dependence
Ahmed Elkashef,Richard A. Rawson,Ann L. Anderson,Shou-Hua Li,Tyson H. Holmes,Edwina V. Smith,Nora Chiang,Roberta Kahn,Frank Vocci,Walter Ling,Valerie Pearce,Michael McCann,Jan Campbell,Charles Gorodetzky,William Haning,Barry S. Carlton,Joseph Mawhinney,Dennis Weis +17 more
TL;DR: The data suggest that bupropion, in combination with behavioral group therapy, was effective for increasing the number of weeks of abstinence in participants with low-to-moderate methamphetamine dependence, mainly male patients, regardless of their comorbid condition.
Journal ArticleDOI
Modafinil for the treatment of cocaine dependence.
Ann L. Anderson,Malcolm S. Reid,Shou Hua Li,Tyson H. Holmes,Lynn Shemanski,April Slee,Edwina V. Smith,Roberta Kahn,Nora Chiang,Frank Vocci,Domenic A. Ciraulo,Charles A. Dackis,John D. Roache,Ihsan M. Salloum,Eugene Somoza,Harold C. Urschel,Ahmed Elkashef +16 more
TL;DR: Data suggest that modafinil, in combination with individual behavioral therapy, was effective for increasing cocaine non-use days in participants without co-morbid alcohol dependence, and in reducing cocaine craving.
Journal ArticleDOI
Bupropion reduces methamphetamine-induced subjective effects and cue-induced craving
Thomas F. Newton,John D. Roache,Richard De La Garza,Timothy W. Fong,Christopher L. Wallace,Shou Hua Li,Ahmed Elkashef,Nora Chiang,Roberta Kahn +8 more
TL;DR: Bupropion reduced acute methamphetamine-induced subjective effects and reduced cue-induced craving, and these data provide a rationale for the evaluation of bupropion in the treatment of methamphetamine dependence.
Journal ArticleDOI
A preliminary randomized, double-blind, placebo-controlled study of the safety and efficacy of ondansetron in the treatment of methamphetamine dependence
Bankole A. Johnson,Nassima Ait-Daoud,Ahmed Elkashef,Edwina V. Smith,Roberta Kahn,Francis Vocci,Shou-Hua Li,Daniel A. Bloch +7 more
TL;DR: The preliminary results do not support the utility of ondansetron, at the doses tested, as a treatment for methamphetamine dependence and should be viewed in light of the possibility that a less intensive cognitive behavioural therapy regimen might have yielded more positive results in this initial phase II trial.
Journal ArticleDOI
Modafinil for the treatment of methamphetamine dependence.
Ann L. Anderson,Shou-Hua Li,Kousick Biswas,Frances McSherry,Tyson H. Holmes,Erin Iturriaga,Roberta Kahn,Nora Chiang,Thomas P. Beresford,Jan Campbell,William Haning,Joseph Mawhinney,Michael J. McCann,Richard A. Rawson,Christopher Stock,Dennis Weis,Elmer Yu,Ahmed Elkashef +17 more
TL;DR: Data suggest that modafinil, plus group behavioral therapy, was not effective for decreasing methamphetamine use, and the study is probably inconclusive because of inadequate compliance with taking medication.